Press release
Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Market is Projected to Reach US$ 6,414.4 Mn by 2025
Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Market
Report Overview @
https://www.transparencymarketresearch.com/exocrine-pancreatic-insufficiency.html
So What's Driving the Projected Growth?
Rising cases of diabetes are expected to fuel growth of the EPI therapeutics and diagnostics market. According to the latest report by the American Diabetes Association, the total population of diabetics around the world is expected to reach 366 mn by 2030. According to Global diabetes community in the UK, 25% to 50% of insulin dependent diabetics developed EPI at a later stage. Diabetes also shares a strong correlation with cystic fibrosis. The rise in technological advancements like big data are expected to propel diagnosis of cystic fibrosis. It is estimated that nearly 90% of the patients with cystic fibrosis develop EPI. The rising cases of diabetes, the increasingly sedentary lifestyle, and worsening environmental conditions are expected to drive growth of the EPI therapeutics and diagnostics market in the near future.
epi therapeutics diagnostics market
Trends to Keep an Eye On
The conventional diagnostic methods in the EPI therapeutics and diagnostics market include blood tests, MRI, and CT scanning. Among these, the CT scans continue to hold the dominant share of the market thanks to their widespread availability, and cost-effectiveness. However, the diagnostic method experiences sluggish growth across various regions due to technological innovation and more accurate diagnostics.
Request Sample @
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2748
On the other hand, MRI or Magnetic Resonance Imaging is expected to register the fastest growth in the EPI therapeutics and diagnostics market. These diagnostics methods are far more sensitive in diagnostics as compared to convention CT scans, and preferred choice for certain diseases. The diagnostics are concerned ideal for chronic pancreatitis, which is expected to be the main driver of growth in the EPI therapeutics and diagnostics market. Hence, the MRI diagnostics are expected to outpace all other forms of diagnostics in the near future.
Weight loss and nutritional diets present a significant opportunity on the horizon in the EPI therapeutics and diagnostics market. EPI results in weight loss for patients as their body is unable to break down fats and protein required. Additionally, the rise of incidences of chronic diseases like HIV, cancer, and lifestyle choices such as smoking are likely to exacerbate the current crisis in preventive healthcare. Moreover, the widespread demand for weight loss treatments, and growing awareness about nutrition are expected to aid growth of the growth. Hence, the rising demand for healthy nutrition and its awareness are expected to be a major boon for the exocrine pancreatic insufficiency therapeutics and diagnostics market.
A Region in Focus
North America:
The growing focus on healthcare in North America is expected to increase awareness about lifestyle diseases like diabetes. It is estimated that each year over 1000 new cases of cystic fibrosis in the US. Based on current winds in the US, healthcare is likely to expand to a far larger population in the near future. This is expected to help growth of the EPI therapeutics and diagnostics market in the near future. Furthermore, in recent years the costs per patient for PERT prescriptions has risen significantly.
Request Brochure @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2748
The widespread consumption of unhealthy foods, sugary diets, and growing population of diabetics are expected to propel the EPI therapeutics and diagnostics market in the near future. The stiff regulations in regards sales and approvals of drugs and therapeutics are expected to remain major challenges in the region. This is likely to be a hindrance in North America as well as Europe in the near future. These regulations can slowdown the entry of new players in the EPI therapeutics and diagnostics market in the North America region.
Contact Us
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR's syndicated reports strive to provide clients to serve their overall research requirement.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Market is Projected to Reach US$ 6,414.4 Mn by 2025 here
News-ID: 1927180 • Views: …
More Releases from Transparency Market Research
Global Solar Powered Agricultural Dryer Market to Exceed USD 2.4 Billion by 2031 …
The global solar powered agricultural dryer market, valued at US$ 1.6 billion in 2022, is projected to grow at a CAGR of 5.8% from 2023 to 2031, reaching US$ 2.4 billion by the end of 2031. Rising investments in renewable energy, growing awareness of sustainable agricultural practices, and the rapid expansion of the agricultural sector driven by population growth are key factors fueling market growth.
Uncover essential discoveries and trends from…
Technetium-99m Market Forecast 2034: Rising Demand for Diagnostic Imaging and Ra …
The global Technetium‐99m Market was valued at US$ 6.0 Billion in 2023 and is projected to grow at a CAGR of 3.3% from 2024 to 2034, surpassing US$ 8.6 Billion by the end of the forecast period. Advancements in nuclear imaging infrastructure, government-backed healthcare initiatives, and an increasing demand for precise diagnostic procedures are fueling this growth.
Discover essential conclusions and data from our Report in this sample -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=77100
Analysts' Viewpoint
The Technetium‐99m…
Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to …
The global Equine Diagnostic Services Market, valued at approximately US$ 168 million in 2019, is projected to expand at a compound annual growth rate (CAGR) of ~5% from 2020 to 2030, reaching around US$ 280 million by 2030. Equine diagnostic services, encompassing tests like genetic, infectious disease, and imaging diagnostics, are critical for managing horse health in veterinary hospitals, clinics, and mobile settings. The market is driven by increasing equine…
Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of …
The digital printing market is experiencing strong growth, driven by rapid technological advancements, rising demand for personalized and on-demand printing, and an increasing focus on sustainable solutions. Digital printing allows for the direct transfer of digital files onto a wide range of substrates, offering high-resolution output with greater speed and flexibility. Its adaptability has led to broad adoption across industries such as packaging, textiles, publishing, and advertising-sectors where customization, efficiency,…
More Releases for EPI
Consumer Electronics Adoption Fuels The Silicon Epi Wafer Market: Core Growth En …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
What Will the Silicon EPI Wafer Industry Market Size Be by 2025?
Over recent years, the market size for silicon EPI wafers has seen considerable growth. Predictions indicate an increase from $1.8 billion in 2024 to $1.92 billion in 2025, representing a compound annual growth rate (CAGR) of 6.8%. Factors contributing to this historical…
Evolving Market Trends In The Silicon EPI Wafer Industry: Next-Generation Silico …
The Silicon EPI Wafer Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Silicon EPI Wafer Market Size During the Forecast Period?
In recent times, the silicon EPI wafer market has witnessed substantial growth. The market size, which stood at $1.8 billion in…
Leading Growth Driver in the Silicon EPI Wafer Market in 2025: Consumer Electron …
What industry-specific factors are fueling the growth of the silicon epi wafer market?
The silicon EPI wafer market is expected to experience significant growth due to the increased use of consumer electronics products. Consumer electronics (CE) refers to electronic devices specifically designed for everyday use by consumers for non-commercial or professional purposes. Silicon wafers, which are semiconductors, are used in the manufacture of microchips and chips for these electronic devices. For…
EPI Invests $1 Million USD in the EPI Data Center Futurist Scholarship Program
Singapore (15 June 2023) - EPI, the global leader in data center training, audit & certification, is proud to announce the launch of the EPI Data Center Futurist Scholarship program, accompanied by a significant investment of one (1) million US-Dollar. This transformative initiative aims to provide aspiring professionals with the resources and support they need to acquire the specialized knowledge and skills necessary for success in the dynamic data…
Epi Wafer Market to Surpass Valuation of US$ 5.8 Bn by 2030 with Rising Demand f …
The global Epi Wafer market is estimated to attain a valuation of US$ 5.8 billion by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 6% during the forecast period, 2021-2031.
The key objective of the TMR report is to offer a complete assessment of the global market including major leading stakeholders of…
Exocrine Pancreatic Insufficiency (EPI) Therapeutics- Pipeline Analysis
Exocrine pancreatic insufficiency (EPI) is the inability of pancreas to produce enough enzymes for the proper breakdown and absorption of nutrients. The common causes of EPI are damage to pancreas, inflammation of pancreas, pancreatic surgery, and inherited disorders like Crohn’s disease and celiac disease.
Download the sample report at: https://www.pharmaproff.com/request-sample/1024
Some symptoms observed during EPI are pain or tenderness in belly, bad-smelling bowel movements, gas, diarrhea and feeling of fullness. EPI…
